Skip to main content

A Phase I trial of PVSRIPO for Patients with Unresectable Melanoma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Istari Oncology

Start Date

October 24, 2018

End Date

February 10, 2022
 

Administered By

Duke Cancer Institute

Awarded By

Istari Oncology

Start Date

October 24, 2018

End Date

February 10, 2022